|Day Low/High||3.52 / 3.76|
|52 Wk Low/High||3.20 / 12.60|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Arbutus Biopharma Corp , where a total volume of 1,263 contracts has been traded thus far today, a contract volume which is representative of approximately 126,300 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 48% of ABUS's average daily trading volume over the past month, of 262,905 shares.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
In trading on Tuesday, shares of Arbutus Biopharma Corp crossed below their 200 day moving average of $7.08, changing hands as low as $6.82 per share. Arbutus Biopharma Corp shares are currently trading off about 20.6% on the day.
In recent trading, shares of Arbutus Biopharma Corp have crossed above the average analyst 12-month target price of $9.88, changing hands for $10.25/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
In recent trading, shares of Arbutus Biopharma Corp have crossed above the average analyst 12-month target price of $7.75, changing hands for $7.85/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Investors in Arbutus Biopharma Corp saw new options become available this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABUS options chain for the new August 17th contracts and identified one put and one call contract of particular interest.
Detailed Data to be Presented at AASLD in October
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.